Cris Calsada | Chief Financial Officer |
Jay Hagan | President & Chief Executive Officer |
Denis Drygin | Chief Scientific Officer |
Shveta Dighe | Wedbush Securities |
Yanan Zhu | Wells Fargo |
Ladies and gentlemen, thank you for standing by and welcome to the Regulus Therapeutics 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there will be question-and-answer session. [Operator Instructions] And please be advised that today's conference is being recorded. [Operator Instructions] I would now like to hand the conference over to Cris Calsada.